Literature DB >> 32936465

Research progress and challenges to coronavirus vaccine development.

Peiwen Zhou1, Zonghui Li2, Linqing Xie3, Dong An4, Yaohua Fan2, Xiao Wang2, Yiwei Li2, Xiaohong Liu2, Jianguo Wu1,2, Geng Li1,2, Qin Li3.   

Abstract

Coronaviruses (CoVs) are nonsegmented, single-stranded, positive-sense RNA viruses highly pathogenic to humans. Some CoVs are known to cause respiratory and intestinal diseases, posing a threat to the global public health. Against this backdrop, it is of critical importance to develop safe and effective vaccines against these CoVs. This review discusses human vaccine candidates in any stage of development and explores the viral characteristics, molecular epidemiology, and immunology associated with CoV vaccine development. At present, there are many obstacles and challenges to vaccine research and development, including the lack of knowledge about virus transmission, pathogenesis, and immune response, absence of the most appropriate animal models.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  animal model; coronavirus; receptor-binding domain; spike protein; vaccine

Year:  2020        PMID: 32936465     DOI: 10.1002/jmv.26517

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  3 in total

Review 1.  Research progress of traditional Chinese medicine against COVID-19.

Authors:  Wei Ren; Pan Liang; Yue Ma; Qin Sun; Qingrong Pu; Li Dong; Gang Luo; Maryam Mazhar; Jiali Liu; Raoqiong Wang; Sijin Yang
Journal:  Biomed Pharmacother       Date:  2021-02-03       Impact factor: 7.419

Review 2.  Composition, Clinical Efficiency, and Mechanism of NHC-Approved "Three Chinese Medicines and Three Chinese Recipes" for COVID-19 Treatment.

Authors:  Ke-Yao Xia; Zeyuan Zhao; Taif Shah; Jing-Yi Wang; Zulqarnain Baloch
Journal:  Front Pharmacol       Date:  2022-02-04       Impact factor: 5.810

Review 3.  Structural Requirements and Plasticity of Receptor-Binding Domain in Human Coronavirus Spike.

Authors:  Yajuan Li; Peiyi Zheng; Tingting Liu; Cuixiao Shi; Bo Wang; Yuanhong Xu; Tengchuan Jin
Journal:  Front Mol Biosci       Date:  2022-07-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.